Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gossamer Bio Inc (GOSS)

Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Gossamer Bio: Q1 Earnings Snapshot

Gossamer Bio: Q1 Earnings Snapshot

GOSS : 0.7423 (-0.44%)
Gossamer Bio: Q4 Earnings Snapshot

Gossamer Bio: Q4 Earnings Snapshot

GOSS : 0.7423 (-0.44%)
Gossamer Bio: Q3 Earnings Snapshot

Gossamer Bio: Q3 Earnings Snapshot

GOSS : 0.7423 (-0.44%)
Gossamer Bio: Q2 Earnings Snapshot

Gossamer Bio: Q2 Earnings Snapshot

GOSS : 0.7423 (-0.44%)
Gossamer Bio: Q1 Earnings Snapshot

Gossamer Bio: Q1 Earnings Snapshot

GOSS : 0.7423 (-0.44%)
Gossamer Bio: Q4 Earnings Snapshot

Gossamer Bio: Q4 Earnings Snapshot

GOSS : 0.7423 (-0.44%)
Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation...

GOSS : 0.7423 (-0.44%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ: GOSS). Such investors...

GOSS : 0.7423 (-0.44%)
Gossamer Bio (GOSS) Upgraded to Buy: What Does It Mean for the Stock?

Gossamer Bio (GOSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

GOSS : 0.7423 (-0.44%)
Gossamer Bio (GOSS) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Gossamer Bio (GOSS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates...

GOSS : 0.7423 (-0.44%)

Barchart Exclusives

3 Dividend Kings That Cut (Or Will Cut) Their Dividends
Dividend aristocracy isn't always a sure thing. Here are 3 companies that have been or will be booted from the coveted king's list. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar